Readoutin 45d
Seagen, a wholly owned subsidiary of Pfizer — disitamab vedotin
Phase 3 primary completion: Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2.
- Date
- Jan 2027
- Type
- Readout
- Indication
- Urothelial Carcinoma